Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
San Carlos, CA
SEC filing record 1 source field available
Fiscal year end
31 December
IOVANCE BIOTHERAPEUTICS, INC. has filed 1,025 SEC EDGAR filings since 29 Jan 2008

SEC filing history

Showing 551-575 of 998 matching filings.

Per page
25
Current page
23
8-K File 001-36860

8-K

Filing date
13 Nov 2017
Reporting date
06 Nov 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36860

8-K

Filing date
31 Oct 2017
Reporting date
31 Oct 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
424B3 File 333-214073

424B3

Filing date
26 Oct 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36860

FORM 8-K

Filing date
26 Oct 2017
Reporting date
26 Oct 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
3

PRIMARY DOCUMENT

Filing date
20 Oct 2017
Reporting date
20 Oct 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
CT ORDER File 001-36860

CT ORDER filing

Filing date
28 Sep 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36860

FORM 8-K

Filing date
26 Sep 2017
Reporting date
25 Sep 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36860

8-K

Filing date
21 Sep 2017
Reporting date
19 Sep 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
424B5 File 333-215320

FINAL PROSPECTUS SUPPLEMENT

Filing date
21 Sep 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
424B5 File 333-215320

424B5

Filing date
19 Sep 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36860

FORM 8-K

Filing date
15 Sep 2017
Reporting date
14 Sep 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
12 Sep 2017
Reporting date
08 Sep 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36860

8-K

Filing date
11 Sep 2017
Reporting date
11 Sep 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36860

8-K

Filing date
06 Sep 2017
Reporting date
31 Aug 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
16 Aug 2017
Reporting date
14 Aug 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
3

PRIMARY DOCUMENT

Filing date
16 Aug 2017
Reporting date
14 Aug 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36860

8-K

Filing date
08 Aug 2017
Reporting date
04 Aug 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
EFFECT File 333-215320

EFFECT filing

Filing date
03 Aug 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
EFFECT File 333-212373

EFFECT filing

Filing date
03 Aug 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
EFFECT File 333-214073

EFFECT filing

Filing date
03 Aug 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-85384

SC 13G/A filing

Filing date
03 Aug 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
POS AM File 333-215320

POS AM

Filing date
31 Jul 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .